Risk of endometrial and breast cancer in patients with diabetes mellitus

International Journal of Cancer

Volumn 71, Issue 3, 1997, Pages 360-363

  Weiderpass, Elisabete ^a   Gridley, Gloria ^b   Persson, Ingemar ^a   Nyrén, Olof ^a   Ekbom, Anders ^a,c   Adami, Hans Olov ^a,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CHILD; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SWEDEN; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; REGISTRIES; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 0031009019     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W     Document Type: Article

References (21)

1. ADAMI, H.-O., MCLAUGHLIN, J. EKBOM, A., BERNE, C. SILVERMAN, D., HACKER, D. and PERSSON, I., Cancer risk in patients with diabetes mellitus. Cancer Causes Control, 2, 307-314 (1991).
2. ADAMI, H.-O., PERSSON, I., EKBOM, A., WOLK, A., PONTÉN, J. and TRICHOPOULOS, D., The aetioloygy and pathogenesis of human breast cancer. Mutation Res., 333, 29-35 (1995).
3. BRINTON, L.A., BERMAN, M.L., MORTEL, R. TWIGGS, L.B., BARRET, R.J., WILBANKS, G.D., LANNOM, L. and HOOVER, R.N., Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Amer. J. Obstet. Gynecol., 167, 1317-1325 (1992).
4. CHAUDHURI, P.K., CHAUDHURI, B. and PATEL, N., Modulation of estrogen receptor by insulin and its biologic significance. Arch. Surg., 121, 1322- 1325 (1986).
5. DANDONA, P., THUSU, K., COOK, S., SNYDER, B., MAKOWSKI, J., ARMSTRONG, D. and NICOTERA, T., Oxidative damage to DNA in diabetes mellitus. Lancet, 347, 444-445 (1996).
6. HARVENGT, C., Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus. Diabete Metab., 18, 71-77 (1992).
7. KAAKS, R., Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control, 7, 605-625 (1996).
8. LA VECCHIA, C., NEGRI, E., FRANCESCHI, S., D' AVANZO, B. and BOYLE, P., A case-control study of diabetes mellitus and cancer risk. Brit. J. Cancer, 70, 950-953 (1994).
9. LEVI, F., F., LA VECCHIA, C., GULIE, C., FRASCESCHI, S. and NEGRI, E., Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates. Europ. J. Cancer, 29, 1445-1449 (1993).
10. MAATELA, J., AROMAA, A., SALMI, T., POHJA, M., VUENTO, M. and GRÖNROOS, M., The risk of endometrial cancer in diabetic and hypertensive patients: a nationwide record-linkage study in Finland. Ann. Chir. Gynae- col., 83, 20-24 (1994).
11. MAGGINO, T., MARCADELLA, C.B. and ROMAGNOLO, C., The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias, a) insulin. Europ. J. Gynaecol. Oncol., 14, 131-134 (1993).
12. MANSON, J.E., RIMM, E.B., COLDITZ, G.A., WILLET, W,C., NATHAN, D.M., ARKY, R.A., ROSNER, B., HENNEKENS, C.H., SPEIZER, F.E. and STAMPFER, M.J., A prospective study of postmenopausal estrogen therapy and subse- quent incidence of non-insulin-dependent diabetes mellitus. Ann. Epide- miol., 2, 665-673 (1992a).
13. MANSON, J.E., RIMM, E.B., COLDITZ, G.A., STAMPFER, M.J., WILLET, W.C., ARKY, R.A., ROSNER, B., HENNEKENS, C.H. and SPEIZER, F.E., Parity and incidence of non-insulin-dependent diabetes mellitus. Amer. J. Med., 93, 13-18 (1992b).
14. MATTSSON, B., RUTQVIST, L.E. and WALLGREN, A., Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int. J. Epide- miol., 14, 64-69 (1985).
15. McPHERSON, C.P., SELLERS, T.A., POTTER, J.D., BOSTICK, R.M. and FOLSOM, A.R., Reproductive factors and risk of endometrial cancer: the Iowa Women's Health Study. Amer. J. Epidemiol., 143, 1195-1101 (1996).
16. NAESSÉN, T., PARKER, R., PERSSON, I., ZACK, M. and ADAMI, H.-O., Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Amer. J. Epidemiol., 130, 289-199 (1989).
17. NYHOLM, H.C., NIELSEN, A.L. and NORUP, P., Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: comparison of clinical and histopathological characteristics. Gynecol. Oncol., 49, 229-235 (1993).
18. O'MARA, B.A., BYERS, T. and SHOENFELD, E., Diabetes mellitus and cancer risk: a multisite case-control study. J. chronic Dis., 38, 435-441 (1985).
19. QUINN, M.A., RUFFE, H., BROWN, J.B. and ENNIS, G., Circulating gonadotro- phins and urinary oestrogens in postmenopausal diabetic women. Aust. N.Z. J. Obstet. Gynaecol., 21, 234-236 (1981).
20. STOLL, B.A., Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated? Breast Cancer Res. Treat., 38, 239-246 (1996).
21. YESHAYA, A., ORVIETO, R., DICKER, D., KARP, M. and BEN-RAFAEL, Z., Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int. J. Fertil. Menopausal Stud., 40, 269-273 (1995).